Research Article

An Investigation on the Risk Factors of Thyroid Diseases in Community Population in Hainan

Table 9

Multivariate logistic regression analysis of the prevalence of thyroid diseases.

VariablesβS.E.WaldpOR95%CI

Gender
 Male (ref)
 Female0.910.1631.45<0.001 2.491.81–3.43
Age
 18–29 (ref)<0.001
 30–391.650.4712.280.2131.442.07–13.06
 40–491.130.436.80<0.001 2.441.32–7.22
 50–590.890.434.340.009 3.091.05–5.63
 60–690.520.421.550.037 5.200.74–3.85
 ≥700.440.440.990.3191.550.66–3.66
BMI
 18.5 ≤ BMI < 2 (ref)0.320
 BMI<18.5−0.300.400.570.4520.740.34–1.63
 24 ≤ BMI<280.190.280.440.5061.200.70–2.08
 BIM ≥ 28−0.040.280.020.8760.960.55–1.66
Smoking
 Yes (ref)
 No0.240.240.930.3351.270.78–2.04
Region
 Suburb (ref)
 Urban0.070.170.150.6961.070.77–1.48
Season
 Spring (ref)2.050.562
 Summer−0.030.210.020.8810.970.64–1.47
 Autumn−0.260.211.630.2010.770.51–1.15
 Winter0.070.240.080.7771.070.66–1.73
Family history of thyroid disease
 Yes (ref)
 No−0.850.2313.96<0.001 0.430.27–0.67
Hyperlipidemia
 Yes (ref)
 No−0.150.200.560.4560.860.58–1.28
Hyperuric acidemia
 Yes (ref)
 No−0.010.170.000.9680.990.71–1.39
Hypertension
 No (ref)
 Yes0.150.180.680.4091.160.82–1.65
Gout disease
 No (ref)
 Yes0.130.230.330.5671.140.72–1.81
TPOAb
 − (ref)
 +0.430.223.740.0531.540.99–2.38
TgAb
− (ref)
+−0.360.252.150.1430.700.43–1.13
Triglyceride
 Normal (ref)2.380.304
 L0.260.430.360.5471.300.56–3.00
 H0.240.162.200.1381.270.92–1.75
Total cholesterol
 Normal (ref)0.150.926
 L−0.091.070.010.9340.920.11–7.41
 H−0.060.160.150.6990.940.69–1.29
LDL
 Normal (ref)0.910.635
 H0.170.180.860.3541.180.83–1.68
HDL
 Normal (ref)
 L0.510.630.650.4201.660.49–5.67
 H−0.080.160.210.6470.930.67–1.28
Serum vitamin D3
 Inadequate
 Amplitude0.010.180.010.9391.010.71–1.44

TPOAb: thyroid peroxidase antibody; TgAb: thyroglobulin antibody; “+”: positive autoantibody; “−”: negative autoantibodies; LDL: low-density lipoprotein; HDL: high-density lipoprotein. “” and bold text represent statistical significance. “” and bold text represent statistical significance.